{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:43:46Z","timestamp":1787240626446,"version":"build-2736575974"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:00:00Z","timestamp":1739491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:00:00Z","timestamp":1739491200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100017655","name":"Incyte Corp.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100017655","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Eli Lilly"},{"name":"Appignani Benefactor Funds"},{"name":"Mayo Clinic Clinical Trials Stimulus Funds"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-025-03996-4","type":"journal-article","created":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T06:38:18Z","timestamp":1739515098000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Repurposing the composite assessment of index lesion severity scoring system in cutaneous lichen planus"],"prefix":"10.1007","volume":"317","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0985-4227","authenticated-orcid":false,"given":"Nan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-6900-2615","authenticated-orcid":false,"given":"Alyssa L.","family":"Stockard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9229-1145","authenticated-orcid":false,"given":"Zachary","family":"Leibovit-Reiben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8769-2916","authenticated-orcid":false,"given":"Angelina S.","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2646-0166","authenticated-orcid":false,"given":"Jacob A.","family":"Kechter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1477-7278","authenticated-orcid":false,"given":"Caitlin M.","family":"Brumfiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8174-0382","authenticated-orcid":false,"given":"Meera H.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0177-2996","authenticated-orcid":false,"given":"Puneet","family":"Bhullar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8243-1960","authenticated-orcid":false,"given":"Colleen","family":"Morken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4743-5530","authenticated-orcid":false,"given":"Blake W.","family":"Boudreaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6594-6143","authenticated-orcid":false,"given":"Shams","family":"Nassir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4353-4574","authenticated-orcid":false,"given":"Miranda","family":"Yousif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0764-4047","authenticated-orcid":false,"given":"Ewoma","family":"Ogbaudu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5524-2750","authenticated-orcid":false,"given":"Fangyi","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2313-5923","authenticated-orcid":false,"given":"Samantha","family":"Zunich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1834-0850","authenticated-orcid":false,"given":"Emily","family":"Branch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9912-1085","authenticated-orcid":false,"given":"Amylou","family":"Dueck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7389-3853","authenticated-orcid":false,"given":"Julia","family":"Lehman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7913-0294","authenticated-orcid":false,"given":"Mark R.","family":"Pittelkow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6873-1705","authenticated-orcid":false,"given":"Aaron R.","family":"Mangold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,14]]},"reference":[{"key":"3996_CR1","volume-title":"Fitzpatrick\u2019s Dermatology, 9e","author":"AR Mangold","year":"2019","unstructured":"Mangold AR, Pittelkow MR (2019) Lichen Planus. In: Kang S, Amagai M, Bruckner AL et al (eds) Fitzpatrick\u2019s Dermatology, 9e. McGraw-Hill Education, New York, NY"},{"issue":"8","key":"3996_CR2","doi-asserted-by":"publisher","first-page":"e461","DOI":"10.1111\/ijd.16563","volume":"62","author":"CM Morken","year":"2023","unstructured":"Morken CM, Bhullar PK, Boudreaux BW et al (2023) Availability of a validated cutaneous lichen planus disease index: a systematic review. Int J Dermatol 62(8):e461\u2013e463","journal-title":"Int J Dermatol"},{"issue":"5","key":"3996_CR3","first-page":"581","volume":"137","author":"M Duvic","year":"2001","unstructured":"Duvic M, Martin AG, Kim Y et al (2001) Phase 2 and 3 clinical trial of oral bexarotene (Targretin Capsules) for the treatment of refractory or persistent early-stage cutaneous T-Cell lymphoma. Arch Dermatol 137(5):581\u2013593","journal-title":"Arch Dermatol"},{"issue":"8","key":"3996_CR4","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1016\/j.jid.2022.01.015","volume":"142","author":"CM Brumfiel","year":"2022","unstructured":"Brumfiel CM, Patel MH, Severson KJ et al (2022) Ruxolitinib cream in the treatment of cutaneous Lichen Planus: a prospective, open-label study. J Invest Dermatol Aug 142(8):2109\u20132116e2104","journal-title":"J Invest Dermatol Aug"},{"key":"3996_CR5","doi-asserted-by":"crossref","unstructured":"Hwang AS, Kechter JA, Do TH et al (2024) Rapid response of lichen planus to baricitinib associated with suppression of cytotoxic CXCL13\u2009+\u2009CD8\u2009+\u2009T-cells. J Clin Invest Nov 14","DOI":"10.1172\/JCI179436"},{"issue":"6","key":"3996_CR6","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1002\/art.1780360601","volume":"36","author":"DT Felson","year":"1993","unstructured":"Felson DT, Anderson JJ, Boers M et al (1993) The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome measures in Rheumatoid Arthritis clinical trials. Arthritis Rheum Jun 36(6):729\u2013740","journal-title":"Arthritis Rheum Jun"},{"issue":"5","key":"3996_CR7","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1002\/(SICI)1097-0142(19990301)85:5<1186::AID-CNCR24>3.0.CO;2-N","volume":"1","author":"TR Mendoza","year":"1999","unstructured":"Mendoza TR, Wang XS, Cleeland CS et al (1999) The rapid assessment of fatigue severity in cancer patients: use of the brief fatigue inventory. Cancer Mar 1(5):1186\u20131196","journal-title":"Cancer Mar"},{"key":"3996_CR8","doi-asserted-by":"crossref","unstructured":"Fawcett T (2006) An introduction to ROC analysis. Pattern Recognition Letters 27(8):861\u2013874","DOI":"10.1016\/j.patrec.2005.10.010"},{"key":"3996_CR9","doi-asserted-by":"publisher","first-page":"456","DOI":"10.3389\/fpsyg.2017.00456","volume":"8","author":"JZ Bakdash","year":"2017","unstructured":"Bakdash JZ, Marusich LR (2017) Repeated measures correlation. Front Psychol 8:456","journal-title":"Front Psychol"},{"issue":"1","key":"3996_CR10","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3390\/jcm11010023","volume":"11","author":"K St\u0119pie\u0144","year":"2022","unstructured":"St\u0119pie\u0144 K, \u017babska E, Rahnama-Hezavah M, Reich A (2022) Lichen Planus activity and damage index (LiPADI)\u2013Creation of the Questionnaire. J Clin Med 11(1):23","journal-title":"J Clin Med"},{"issue":"7","key":"3996_CR11","first-page":"e140","volume":"58","author":"A Bishnoi","year":"2019","unstructured":"Bishnoi A, Vinay K, Sendhil Kumaran M, Handa S, Parsad D (2019) Proposition of a comprehensive score to assess the disease severity and activity of cutaneous lichen planus. Int J Dermatol Jul 58(7):e140\u2013e142","journal-title":"Int J Dermatol Jul"},{"issue":"2","key":"3996_CR12","doi-asserted-by":"publisher","first-page":"169","DOI":"10.4103\/ijdvl.IJDVL_650_17","volume":"86","author":"H Kaur","year":"2020","unstructured":"Kaur H, Nikam BP, Jamale VP, Kale MS (2020) Lichen Planus Severity Index: a new, valid scoring system to assess the severity of cutaneous lichen planus. Indian J Dermatol Venereol Leprol Mar-Apr 86(2):169\u2013175","journal-title":"Indian J Dermatol Venereol Leprol Mar-Apr"},{"key":"3996_CR13","unstructured":"Aaron R, Mangold ZL, Rong R, Nawaz H, Ferreira-Cornwell C (2024) PhD. Efficacy and safety of ruxolitinib cream in patients with cutaneous lichen planus: results from a phase 2, randomized, vehicle-controlled study. In: 33rd European Academy of Dermatology and Venereology Congress; 25\u201328 September 2024; Amsterdam TN, ed"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-025-03996-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-025-03996-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-025-03996-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T18:09:32Z","timestamp":1739556572000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-025-03996-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,14]]},"references-count":13,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3996"],"URL":"https:\/\/doi.org\/10.1007\/s00403-025-03996-4","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,14]]},"assertion":[{"value":"19 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Funding sources of the paper include: Incyte Corp. and Eli Lilly, Appignani Benefactor Funds, 5P30AR075043, Mayo Clinic Clinical Trials Stimulus FundsConflicts of interest: The authors declare the following competing interests: Dr. Aaron R. Mangold has consulted for Phlecs BV, Kyowa, Eli Lilly, Momenta, UCB, and Regeneron in the past, greater than 24 months ago. He has consulted for Incyte, Soligenix, Clarivate, Argenyx, and Bristol Myers Squibb in the past, less than 12 months ago. He consults for Nuvig, Tourmaline Bio, Janssen, Boehringer Ingelheim currently. He consults for Regeneron and Pfizer currently with payments to the institution. He has grant support from Kyowa, Miragen, Regeneron, Corbus, Pfizer, Incyte, Eli Lilly, Argenx, Palvella, Abbvie, Priovant, Bristol Myers Squibb, Merck in the last 24 months. Beyond 24 months, grant support has come from Sun Pharma, Elorac, Novartis, and Janssen. He has received royalties from Adelphi Values and Clarivate. His current patents include Methods and Materials for assessing and treating cutaneous squamous cell carcinoma (PCT\/US2023\/078902), Use of Oral Jaki in Lichen Planus- PCT\/US2024\/020149; and Topical Ruxolitinib in Lichen Planus- PCT\/US2021\/053149, 2023-520085, & 21805700.8, respectively. Methods and Materials for Treating Lichen Planopilaris (Registration Number: 53,103), Machine-Learning Models for Tumor Grading Using Rank-Aware Contextual Reasoning on Whole Slide Images (63\/616,287). JC declares to have received Grants to institution: Castle-Biosciences, Regeneron Pharmaceuticals; Lectures honoraria: Sanofi, Almirall, Abbvie, Regeneron, Sun Pharma; Payment for expert testimony: Sanofi, Regeneron, Almirall; Support for attending meetings: Pfyzer, Almirall, Lilly; Advisory board: Almirall, Sanofi, Regeneron, Kyowa, Roche, InflaRx.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Approved by the Mayo Clinic Institutional Review Board 21-003075 and 17-005406.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"IRB approval status"}}],"article-number":"413"}}